Cervical Cancer. Malignant neoplasm of cervix uteri, unspecified
Conditions
Interventions
Intervention 1: Intervention group: The first group of the intervention will be in such a way that at first the participants will be members of the ITA group. After welcoming and introducing himself,
Then the time and place of the first training session was announced in the groupThe schedule of training sessions will be in person one day a week. These sessions include 2 training sessions to increa
Sponsors
Tarbiat Modares University
Eligibility
Sex/Gender
Female
Age
30 Years to 59 Years
Inclusion criteria
Inclusion criteria: 1. A resident of Saveh city Covered by the centers and has an active electronic file of the Sib system Age between 30 and 59 years Having marriage experience More than 3 years have passed since the first sex Obtaining a weak and average knowledge score in the first stage of study Using a smart mobile phone to use virtual networks (ITA) Desire to participate in research
Exclusion criteria
Exclusion criteria: 1. Participation in another educational program at the same time or parallel to the intervention Being pregnant now Perform hysterectomy Genital warts or cervical cancer known and under treatment Conducting a pap smear test in the last 2 years Conducting HPV screening tests in the last 10 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Knowledge score in the Farsi version of cervical cancer screening self-efficacy questionnaire. Timepoint: Before the intervention, immediately, one month later and three months after the intervention. Method of measurement: Persian version of cervical cancer screening self-efficacy questionnaire.;Attitude score in the Persian version of cervical cancer screening self-efficacy questionnaire. Timepoint: Before the intervention, immediately, one month later and three months after the intervention. Method of measurement: Persian version of cervical cancer screening self-efficacy questionnaire.;Self-efficacy score in the Farsi version of cervical cancer screening self-efficacy scale. Timepoint: Before the intervention, immediately, one month later and three months after the intervention. Method of measurement: Persian version of cervical cancer screening self-efficacy questionnaire.;Practice score in the Farsi version of cervical cancer screening self-efficacy questionnaire. Timepoint: Before the intervention, immediately, one month later and three months after the intervention. Method of measurement: Persian version of cervical cancer screening self-efficacy questionnaire.;Adhereance to action score in Persian version of the Adhereance to action pap smear. Timepoint: Before the intervention, immediately, one month later and three months after the intervention. Method of measurement: Persian version of the Adhereance to action pap smear. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Zarei
Tarbiat Modares University
Outcome results
None listed